Results 171 to 180 of about 50,320 (220)

Requiem for mineralocorticoid blockade in maintenance dialysis. [PDF]

Lancet
Soomro QH, Charytan DM.
europepmc   +1 more source

Different aspects of pharmacological heart failure treatment. [PDF]

Eur Heart J Cardiovasc Pharmacother
Agewall S.
europepmc   +1 more source

Beneficial Impact of Spironolactone Add-on Therapy on Cardiac Mass Index in Patients with Difficult-to-Manage Hypertension

Ameer Karavathukudy Azeez, Dhanasekaran Mayavan, Venkateswaran Munisamy   +2 more
openalex   +1 more source

Androgenic hidradenitis suppurativa onset linked to gamma secretase inhibitor. [PDF]

JAAD Case Rep
Tai H, Hill KT, Parvathaneni A, Islam Z, Cohen SR.   +4 more
europepmc   +1 more source

Lead-induced hypertension and cognitive dysfunction: brain amyloid pathology. [PDF]

Eur J Med Res
Zhang Y, Xu Y, Song Y, Wang Y, Chen M, Ji X, Lin Y, Gu S.   +7 more
europepmc   +1 more source

The paradox of spironolactone: A heart failure treatment with potentially harmful effects

Muhammad Roshan, Muhammad Nadeem, Sahar Imran Khalfay   +2 more
openalex   +2 more sources

Mineralocorticoid receptor antagonists reduce inflammatory signaling independent of myofiber mineralocorticoid receptor. [PDF]

Endocr Metab Sci
Lowe J, Piepho AB, Gomatam CK, Debell P, Ballinger MN, Rafael-Fortney JA.   +5 more
europepmc   +1 more source

Cardiovascular-Kidney-Metabolic Effects: Steroidal and Nonsteroidal Mineralocorticoid Receptor Antagonists. [PDF]

Rev Cardiovasc Med
Bozkurt B, Januzzi JL, Bansal S.
europepmc   +1 more source

Effect of spironolactone on monocyte subsets in atrial fibrillation: IMPRESS-AF randomised controlled trial. [PDF]

Sci Rep
Shahid F, Shantsila E, Shantsila A, Lip GYH.   +3 more
europepmc   +1 more source

Molecular characterization of the inhibition of HIV transcription by the spironolactone

, 2016
Benoı̂t Lacombe
openalex   +1 more source